Lars Videbæk

5.4k total citations · 1 hit paper
81 papers, 2.2k citations indexed

About

Lars Videbæk is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lars Videbæk has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lars Videbæk's work include Cardiovascular Function and Risk Factors (37 papers), Heart Failure Treatment and Management (30 papers) and Cardiac pacing and defibrillation studies (19 papers). Lars Videbæk is often cited by papers focused on Cardiovascular Function and Risk Factors (37 papers), Heart Failure Treatment and Management (30 papers) and Cardiac pacing and defibrillation studies (19 papers). Lars Videbæk collaborates with scholars based in Denmark, United States and United Kingdom. Lars Videbæk's co-authors include Jacob Eifer Møller, Finn Gustafsson, Morten Schou, Mikael Kjær Poulsen, Jordi Sanchez Dahl, Per Hildebrandt, Lars Køber, Caroline Kistorp, Patricia A. Pellikka and Henrik Wiggers and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Lars Videbæk

75 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

2016 381 citations Anders Jorsal, Caroline Kistorp et al. European Journal of Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Videbæk Denmark	27	1.5k	674	396	363	323	81	2.2k
Masanori Fujii Japan	27	2.0k 1.3×	555 0.8×	426 1.1×	392 1.1×	308 1.0×	64	2.6k
John F. Setaro United States	21	1.5k 0.9×	559 0.8×	358 0.9×	200 0.6×	374 1.2×	44	2.2k
Allan Kofoed‐Enevoldsen Denmark	20	914 0.6×	962 1.4×	362 0.9×	280 0.8×	243 0.8×	49	2.6k
Ciro Mauro Italy	23	953 0.6×	543 0.8×	374 0.9×	461 1.3×	137 0.4×	87	1.9k
Roland Willenbrock Germany	20	1.4k 0.9×	600 0.9×	441 1.1×	597 1.6×	556 1.7×	55	2.9k
Renaud Fay France	24	1.2k 0.8×	270 0.4×	412 1.0×	195 0.5×	338 1.0×	67	2.1k
Camilla Hage Sweden	30	2.2k 1.4×	382 0.6×	321 0.8×	266 0.7×	220 0.7×	110	2.7k
Paul Milliez France	24	1.9k 1.2×	1.3k 1.9×	1.1k 2.8×	551 1.5×	271 0.8×	111	3.1k
Izuru Masuda Japan	22	1.1k 0.7×	210 0.3×	350 0.9×	422 1.2×	249 0.8×	77	1.8k
Ki‐Dong Yoo South Korea	26	923 0.6×	327 0.5×	675 1.7×	239 0.7×	160 0.5×	125	1.7k

Countries citing papers authored by Lars Videbæk

Since Specialization

Citations

This map shows the geographic impact of Lars Videbæk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Videbæk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Videbæk more than expected).

Fields of papers citing papers by Lars Videbæk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Videbæk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Videbæk. The network helps show where Lars Videbæk may publish in the future.

Co-authorship network of co-authors of Lars Videbæk

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Videbæk. A scholar is included among the top collaborators of Lars Videbæk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Videbæk. Lars Videbæk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butt, Jawad H., Jens Jakob Thune, Lars Videbæk, et al.. (2025). Long-Term Effect of ICDs in Nonischemic Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 86(24). 2402–2414.

Butt, Jawad H., Jens Jakob Thune, Jens Cosedis Nielsen, et al.. (2024). Anthropometric Measures and Long-Term Mortality in Non-Ischaemic Heart Failure with Reduced Ejection Fraction: Questioning the Obesity Paradox. European Journal of Heart Failure. 27(3). 527–536. 6 indexed citations

Thune, Jens Jakob, Jens Cosedis Nielsen, Jens Haarbo, et al.. (2023). Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH. Circulation Heart Failure. 16(10). e010606–e010606.

Butt, Jawad H., Adelina Yafasova, Jens Cosedis Nielsen, et al.. (2023). Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial. Circulation. 148(15). 1179–1181. 1 indexed citations

Banke, Ann, Morten Schou, Marianne Ewertz, et al.. (2021). Immediate evaluation of global longitudinal strain at initiation of trastuzumab treatment in breast cancer patients. Echocardiography. 38(10). 1702–1710. 3 indexed citations

Banke, Ann, Emil Loldrup Fosbøl, Marianne Ewertz, et al.. (2019). Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab. JACC Heart Failure. 7(3). 217–224. 42 indexed citations

Østergaard, Birte, Romy Mahrer Imhof, Lis Wagner, et al.. (2018). Effect of family nursing therapeutic conversations on health-related quality of life, self-care and depression among outpatients with heart failure: A randomized multi-centre trial. Patient Education and Counseling. 101(8). 1385–1393. 31 indexed citations

Schou, Morten, Gunnar Gislason, Lars Videbæk, et al.. (2014). Effect of Extended Follow-Up in a Specialized Heart Failure Clinic on Adherence to Guideline Recommended Therapy: NorthStar Adherence Study. European Journal of Heart Failure. 16(11). 1249–1255. 19 indexed citations

Dahl, Jordi Sanchez, Axel Brandes, Lars Videbæk, et al.. (2014). Atrial fibrillation in severe aortic valve stenosis — Association with left ventricular left atrial remodeling. University of Southern Denmark Research Portal (University of Southern Denmark). 4. 102–107. 7 indexed citations

10.

Jorsal, Anders, Henrik Wiggers, Pernille Holmager, et al.. (2014). A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study). BMJ Open. 4(5). e004885–e004885. 23 indexed citations

11.

Schou, Morten, Finn Gustafsson, Lars Videbæk, et al.. (2013). Adding Serial N-Terminal Pro Brain Natriuretic Peptide Measurements to Optimal Clinical Management in Outpatients with Systolic Heart Failure: A Multicentre Randomized Clinical Trial (NorthStar Monitoring Study). European Journal of Heart Failure. 15(7). 818–827. 30 indexed citations

12.

Schou, Morten, Christian Torp‐Pedersen, Lars Køber, et al.. (2013). Patient Adherence to Evidence-Based Pharmacotherapy in Systolic Heart Failure and the Transition of Follow-Up from Specialized Heart Failure Outpatient Clinics to Primary Care. European Journal of Heart Failure. 15(6). 671–678. 35 indexed citations

13.

Brouwers, Corline, et al.. (2012). Association between psychological measures and brain natriuretic peptide in heart failure patients. Scandinavian Cardiovascular Journal. 46(3). 154–162. 11 indexed citations

14.

Østergaard, Birte, et al.. (2012). Family Focused Nursing for outpatients with heart failure - a randomized multicenter trial. European Journal of Cardiovascular Nursing. 11. 1 indexed citations

15.

Balling, Louise, Morten Schou, Lars Videbæk, et al.. (2011). Prevalence and Prognostic Significance of Hyponatraemia in Outpatients with Chronic Heart Failure. European Journal of Heart Failure. 13(9). 968–973. 65 indexed citations

16.

Dahl, Jordi Sanchez, Lars Videbæk, Mikael Kjær Poulsen, et al.. (2011). Noninvasive assessment of filling pressure and left atrial pressure overload in severe aortic valve stenosis: Relation to ventricular remodeling and clinical outcome after aortic valve replacement. Journal of Thoracic and Cardiovascular Surgery. 142(3). e77–e83. 51 indexed citations

17.

Gustafsson, Finn, et al.. (2009). Incidence and Predictors of Hospitalization or Death in Patients Managed in Multidisciplinary Heart Failure Clinics. European Journal of Heart Failure. 11(4). 413–419. 18 indexed citations

18.

Diederichsen, Axel Cosmus Pyndt, Jacob Eifer Møller, Per Thayssen, et al.. (2008). Effect of Repeated Intracoronary Injection of Bone Marrow Cells in Patients with Ischaemic Heart Failure The Danish Stem Cell Study—Congestive Heart Failure Trial (DanCell-CHF). European Journal of Heart Failure. 10(7). 661–667. 32 indexed citations

19.

Gustafsson, Finn, Morten Schou, Lars Videbæk, et al.. (2007). Treatment with Beta-Blockers in Nurse-Led Heart Failure Clinics: Titration Efficacy and Predictors of Failure. European Journal of Heart Failure. 9(9). 910–916. 30 indexed citations

20.

Mikkelsen, Kurt V., et al.. (2006). Tei Index and Neurohormonal Activation in Patients with Incident Heart Failure: Serial Changes and Prognostic Value. European Journal of Heart Failure. 8(6). 599–608. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact